112 related articles for article (PubMed ID: 10783360)
1. Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration.
Larner JM; Reel JR; Blye RP
Hum Reprod; 2000 May; 15(5):1100-6. PubMed ID: 10783360
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of mifepristone in capsule versus tablet form in healthy nonpregnant women.
Liao A; Pang X; Li H; Xiong Z; Wu X
Contraception; 2008 Jun; 77(6):431-4. PubMed ID: 18477493
[TBL] [Abstract][Full Text] [Related]
3. Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats.
Reel JR; Hild-Petito S; Blye RP
Contraception; 1998 Aug; 58(2):129-36. PubMed ID: 9773268
[TBL] [Abstract][Full Text] [Related]
4. Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis).
Tarantal AF; Hendrickx AG; Matlin SA; Lasley BL; Gu QQ; Thomas CA; Vince PM; Van Look PF
Contraception; 1996 Aug; 54(2):107-15. PubMed ID: 8842588
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action.
Heikinheimo O; Kekkonen R; Lähteenmäki P
Contraception; 2003 Dec; 68(6):421-6. PubMed ID: 14698071
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mifepristone after low oral doses.
Kekkonen R; Heikinheimo O; Mandelin E; Lähteenmäki P
Contraception; 1996 Oct; 54(4):229-34. PubMed ID: 8922876
[TBL] [Abstract][Full Text] [Related]
7. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.
Attardi BJ; Burgenson J; Hild SA; Reel JR; Blye RP
Mol Cell Endocrinol; 2002 Feb; 188(1-2):111-23. PubMed ID: 11911951
[TBL] [Abstract][Full Text] [Related]
8. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.
Perlin E; Smith CG; Nichols AI; Almirez R; Flora KP; Cradock JC; Peck CC
J Pharm Sci; 1985 Feb; 74(2):171-4. PubMed ID: 2985774
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 10 mg of mifepristone.
Leminen R; Ranta S; von Hertzen H; Oehler J; Heikinheimo O
Contraception; 2003 Dec; 68(6):427-9. PubMed ID: 14698072
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic properties of CDB(VA)-2914.
Gainer EE; Ulmann A
Steroids; 2003 Nov; 68(10-13):1005-11. PubMed ID: 14667993
[TBL] [Abstract][Full Text] [Related]
11. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
Attardi BJ; Burgenson J; Hild SA; Reel JR
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):277-88. PubMed ID: 15120421
[TBL] [Abstract][Full Text] [Related]
12. CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits.
Hild SA; Reel JR; Hoffman LH; Blye RP
Hum Reprod; 2000 Apr; 15(4):822-9. PubMed ID: 10739827
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness.
Sarkar NN
Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):113-20. PubMed ID: 11858883
[TBL] [Abstract][Full Text] [Related]
14. Development of l-CDB-4022 as a nonsteroidal male oral contraceptive: induction and recovery from severe oligospermia in the adult male cynomolgus monkey (Macaca fascicularis).
Hild SA; Marshall GR; Attardi BJ; Hess RA; Schlatt S; Simorangkir DR; Ramaswamy S; Koduri S; Reel JR; Plant TM
Endocrinology; 2007 Apr; 148(4):1784-96. PubMed ID: 17218411
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
[TBL] [Abstract][Full Text] [Related]
16. Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers.
Crevoisier C; Delisle MC; Joseph I; Foletti G
Eur Neurol; 2003; 49(3):173-7. PubMed ID: 12646763
[TBL] [Abstract][Full Text] [Related]
17. Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception?
Leminen R; Raivio T; Ranta S; Oehler J; von Hertzen H; Jänne OA; Heikinheimo O
Eur J Endocrinol; 2005 Mar; 152(3):411-8. PubMed ID: 15757858
[TBL] [Abstract][Full Text] [Related]
18. Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.
Passaro MD; Piquion J; Mullen N; Sutherland D; Zhai S; Figg WD; Blye R; Nieman LK
Hum Reprod; 2003 Sep; 18(9):1820-7. PubMed ID: 12923133
[TBL] [Abstract][Full Text] [Related]
19. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey.
Jones KO; Owusu-Ababio G; Vick AM; Khan MA
J Pharm Sci; 2006 Nov; 95(11):2499-506. PubMed ID: 16886208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
